206 related articles for article (PubMed ID: 35492364)
1. New Insights Into Pathophysiology of β-Thalassemia.
Sanchez-Villalobos M; Blanquer M; Moraleda JM; Salido EJ; Perez-Oliva AB
Front Med (Lausanne); 2022; 9():880752. PubMed ID: 35492364
[TBL] [Abstract][Full Text] [Related]
2. Emerging Therapies in β-Thalassemia.
Bou-Fakhredin R; Kuo KHM; Taher AT
Hematol Oncol Clin North Am; 2023 Apr; 37(2):449-462. PubMed ID: 36907614
[TBL] [Abstract][Full Text] [Related]
3. Novel Therapeutic Advances in β-Thalassemia.
Makis A; Voskaridou E; Papassotiriou I; Hatzimichael E
Biology (Basel); 2021 Jun; 10(6):. PubMed ID: 34207028
[TBL] [Abstract][Full Text] [Related]
4. Recent trends in treatment of thalassemia.
El-Beshlawy A; El-Ghamrawy M
Blood Cells Mol Dis; 2019 May; 76():53-58. PubMed ID: 30792169
[TBL] [Abstract][Full Text] [Related]
5. Beta-thalassemia.
Cao A; Galanello R
Genet Med; 2010 Feb; 12(2):61-76. PubMed ID: 20098328
[TBL] [Abstract][Full Text] [Related]
6. Emerging therapies in β-thalassemia: toward a new era in management.
Bou-Fakhredin R; Tabbikha R; Daadaa H; Taher AT
Expert Opin Emerg Drugs; 2020 Jun; 25(2):113-122. PubMed ID: 32249632
[TBL] [Abstract][Full Text] [Related]
7. Thalassemia: pathophysiology of red cell changes.
Schrier SL
Annu Rev Med; 1994; 45():211-8. PubMed ID: 8198378
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of beta thalassemia--a guide to molecular therapies.
Thein SL
Hematology Am Soc Hematol Educ Program; 2005; ():31-7. PubMed ID: 16304356
[TBL] [Abstract][Full Text] [Related]
9. β-Thalassemia.
Origa R
Genet Med; 2017 Jun; 19(6):609-619. PubMed ID: 27811859
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology and treatment of patients with beta-thalassemia - an update.
Fibach E; Rachmilewitz EA
F1000Res; 2017; 6():2156. PubMed ID: 29333256
[TBL] [Abstract][Full Text] [Related]
11. Unmet needs in β-thalassemia and the evolving treatment landscape.
Njeim R; Naouss B; Bou-Fakhredin R; Haddad A; Taher A
Transfus Clin Biol; 2024 Feb; 31(1):48-55. PubMed ID: 38128605
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of heme oxygenase ameliorates anemia and reduces iron overload in a β-thalassemia mouse model.
Garcia-Santos D; Hamdi A; Saxova Z; Fillebeen C; Pantopoulos K; Horvathova M; Ponka P
Blood; 2018 Jan; 131(2):236-246. PubMed ID: 29180398
[TBL] [Abstract][Full Text] [Related]
13. Introduction to the Thalassemia Syndromes: Molecular Medicine's Index Case.
Benz EJ
Hematol Oncol Clin North Am; 2023 Apr; 37(2):245-259. PubMed ID: 36907601
[TBL] [Abstract][Full Text] [Related]
14. Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation.
Motta I; Bou-Fakhredin R; Taher AT; Cappellini MD
Drugs; 2020 Jul; 80(11):1053-1063. PubMed ID: 32557398
[TBL] [Abstract][Full Text] [Related]
15. Differential regulatory and compensatory responses in hematopoiesis/erythropoiesis in alpha- and beta-globin hemizygous mice.
Beauchemin H; Blouin MJ; Trudel M
J Biol Chem; 2004 May; 279(19):19471-80. PubMed ID: 15004025
[TBL] [Abstract][Full Text] [Related]
16. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.
Gardenghi S; Grady RW; Rivella S
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1089-107. PubMed ID: 21075282
[TBL] [Abstract][Full Text] [Related]
17. [Research progress of iron metabolism in phenotype modification of β-thalassemia].
Chen D; Sun X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jan; 38(1):27-31. PubMed ID: 33423253
[TBL] [Abstract][Full Text] [Related]
18. Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia.
Mettananda S; Fisher CA; Hay D; Badat M; Quek L; Clark K; Hublitz P; Downes D; Kerry J; Gosden M; Telenius J; Sloane-Stanley JA; Faustino P; Coelho A; Doondeea J; Usukhbayar B; Sopp P; Sharpe JA; Hughes JR; Vyas P; Gibbons RJ; Higgs DR
Nat Commun; 2017 Sep; 8(1):424. PubMed ID: 28871148
[TBL] [Abstract][Full Text] [Related]
19. Beta-thalassemia: renal complications and mechanisms: a narrative review.
Demosthenous C; Vlachaki E; Apostolou C; Eleftheriou P; Kotsiafti A; Vetsiou E; Mandala E; Perifanis V; Sarafidis P
Hematology; 2019 Dec; 24(1):426-438. PubMed ID: 30947625
[TBL] [Abstract][Full Text] [Related]
20. 2021 update on clinical trials in β-thalassemia.
Musallam KM; Bou-Fakhredin R; Cappellini MD; Taher AT
Am J Hematol; 2021 Nov; 96(11):1518-1531. PubMed ID: 34347889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]